Abstract
Among human cancers, melanoma is characterized by an almost unique predisposition to regress in response to immune therapy. Recent clinical studies suggest that the frequency of this favorable event is enhanced by combining T-cell-directed active specific immunization with the systemic administration of interleukin (IL)-2. While waiting for additional clinical experience to confirm this observation, we embraced the working hypothesis that this combination provides superior response rates than either treatment alone. In particular, we have focused our interest on the paradoxical observation that active specific immunization consistently induces circulating CD8+ T cells capable of recognizing in ex vivo assays tumor cells, but cannot induce tumor regression alone. In these settings, it appears that combining the systemic administration of IL-2 is almost an absolute requirement for the induction of clinical responses. Here, we will expand on previous speculations on the postulated mechanism(s) of action of systemic IL-2 administration and, based on original data recently derived through high-throughput transcriptional and post-translational analysis, we will suggest an explanation for the eclectic effects of IL-2 administration in...Continue Reading
References
Oct 1, 1989·Annals of Surgery·S A RosenbergD E White
Mar 1, 1994·Clinical and Experimental Immunology·D J DeehanO Eremin
Sep 1, 1993·Drugs·Ruth Whittington, Diana Faulds
Apr 1, 1997·Immunology Today·S A Rosenberg
Jun 1, 1997·Immunology Today·T BoonB Van den Eynde
Mar 21, 1998·Nature Medicine·S A RosenbergD E White
Dec 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·M B EisenD Botstein
Apr 5, 2000·Nature Biotechnology·E WangF M Marincola
Apr 11, 2001·Human Immunology·A Khani-HanjaniP Keown
Jan 1, 1994·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·H. BaehrendtzC. Silfverswärd
May 23, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Vladia MonsurròFrancesco M Marincola
Jun 1, 2002·Human Immunology·David TurnerCristina Navarrete
Sep 10, 2002·Transplant Immunology·Leigh J Keen
Oct 29, 2002·Trends in Immunology·Alberto MantovaniAntonio Sica
Jan 4, 2003·Nature Reviews. Immunology·Siamon Gordon
Apr 2, 2003·Cancer Immunology, Immunotherapy : CII·Agnieszka MasztalerzLinda A Everse
Jun 18, 2003·Trends in Immunology·Francesco M MarincolaSoldano Ferrone
Citations
Jan 25, 2005·Springer Seminars in Immunopathology·Ena WangFrancesco M Marincola
Aug 5, 2004·Current Oncology Reports·Monica C PanelliFrancesco M Marincola
Mar 6, 2004·Seminars in Cancer Biology·Vladia MonsurròFrancesco M Marincola
Oct 7, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Geoffrey R WeissEna Wang
Jun 30, 2006·Journal of Translational Medicine·Ping JinFrancesco M Marincola
Aug 18, 2006·Journal of Translational Medicine·Ruggero RidolfiAngela Riccobon
Feb 9, 2006·Journal of Translational Medicine·L GabrieleF M Belardelli
Dec 1, 2007·Journal of Translational Medicine·Dirk NagorsenChristoph Loddenkemper
Jun 19, 2009·Journal of Translational Medicine·Hideaki TaharaFrancesco M Marincola
Jul 20, 2010·Immunotherapy·Beatrix KotlanFrancesco M Marincola
Feb 24, 2005·Journal of Immunotherapy·Michael T LotzeTheresa L Whiteside
Jun 4, 2010·Expert Review of Vaccines·Davide BedognettiFrancesco M Marincola
Feb 26, 2008·Expert Opinion on Biological Therapy·Ena WangFrancesco M Marincola
May 25, 2004·Expert Opinion on Biological Therapy·Monica C PanelliFrancesco M Marincola
Jun 4, 2004·Journal of Translational Medicine·Monica C PanelliFrancesco M Marincola
Nov 20, 2003·Journal of Translational Medicine·Ping Jin, Ena Wang
Dec 4, 2004·PLoS Medicine·Tor B StugePeter P Lee
Oct 7, 2015·PloS One·Shuai ZhaoJian Huang
Oct 17, 2013·British Journal of Cancer·D BedognettiF M Marincola
Aug 19, 2006·Immunological Investigations·Ena WangFrancesco M Marincola
Mar 7, 2009·Cancer Immunology, Immunotherapy : CII·Andrea WorschechAladar A Szalay
Oct 8, 2020·Journal for Immunotherapy of Cancer·Ena WangFrancesco Marincola
May 18, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Monica C PanelliFrancesco M Marincola